- Microsoft, a trillion-dollar company, has seen growth in its cloud computing arm, Microsoft Azure, with revenue jumping 18% year over year to $77.7 billion in Q1 2026. Azure’s momentum, fueled by AI demand, and IP rights from OpenAI, positions Microsoft for strong growth and dividend growth potential.
- Eli Lilly, another trillion-dollar company, achieved success with tirzepatide, a top-selling drug, replacing Keytruda. Despite a market cap dip, tirzepatide’s efficacy in various fields and strong pipeline make Eli Lilly a leader in weight management drugs, with a solid dividend program showing 194% growth over the past decade.
Read more at Nasdaq: 2 Trillion-Dollar Dividend Stocks to Buy and Hold for 10 Years